メインメニューを開く 本文に進む

共同研究者/施設紹介

HUH HEE JAE

Nationality Republic of Korea

Education

  • 2003-2008

    M.D. Ewha Womans University, College of Medicine, Seoul, Korea

  • 2011-2013

    M.S. Sungkyunkwan University School of Medicine, Seoul, Korea

  • 2013-2015

    Ph.D. Sungkyunkwan University School of Medicine, Seoul, Korea

Professional Activities or Employment History

  • 03/2008-02/2009

    Internship at Samsung Medical Center

  • 03/2009-02/2013

    Residency in Department of Laboratory Medicine & Genetics at Samsung Medical Center

  • 03/2013-02/2015

    Fellowship in Department of Laboratory Medicine & Genetics at Samsung Medical Center

  • 03/2015-02/2020

    Clinical Assistant Professor, Department of Laboratory Medicine & Genetics, Samsung Medical Center

  • 03/2020~

    Assistant Professor, Sungkyunkwan University School of Medicine

Licence and Certification

  • 2009-Present

    Medical license, South Korea

  • 2013-Present

    Board of Laboratory Medicine, Certified by Korean Society for Laboratory Medicine

Professional Memberships

  • 2009-Present

    The Korean Society for Laboratory Medicine

  • 2012-Present

    The Korean Society of Clinical Microbiology

  • 2011-Present

    he Korean Society for Genetic Diagnostics

  • 2015-Present

    American Society for Microbiology

Peer Reviewed Publications (recent 3 years)

  1. Yoon Y, Choi JS, Park M, Cho H, Park M, Huh HJ, Kim YJ, Son MH. 2021. Influenza Vaccine Effectiveness in Children at the Emergency Department during the 2018-2019 Season: the First Season School-aged Children Were Included in the Korean Influenza National Immunization Program. J Korean Med Sci 36:e71.
  2. Yoo IY, Shim HJ, Yun SA, Kang OK, Chung YN, Kim TY, Lee H, Kim J, Park YJ, Huh HJ*, Lee NY. 2021. Evaluation of the ASTA MicroIDSys matrix-assisted laser desorption ionization time-of-flight mass spectrometry system for identification of mycobacteria directly from positive MGIT liquid cultures. Int J Infect Dis 102:172-177.
  3. Namkoong H, Omae Y, Asakura T, Ishii M, Suzuki S, Morimoto K, Kawai Y, Emoto K, Oler AJ, Szymanski EP, Yoshida M, Matsuda S, Yagi K, Hase I, Nishimura T, Sasaki Y, Asami T, Shiomi T, Matsubara H, Shimada H, Hamamoto J, Jhun BW, Kim SY, Huh HJ, Won HH, Ato M, Kosaki K, Betsuyaku T, Fukunaga K, Kurashima A, Tettelin H, Yanai H, Mahasirimongkol S, Olivier KN, Hoshino Y, Koh WJ, Holland SM, Tokunaga K, Hasegawa N. 2021. Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease. Eur Respir J doi:10.1183/13993003.02269-2019.
  4. Lee H, Oh J, Sung GH, Koo J, Lee MH, Lee HJ, Cho SI, Choi JS, Park YJ, Shin JH, Lee HK, Kim SY, Lee CH, Kim YR, Sohn YH, Kim WJ, Ryu SW, Lee NY, Huh HJ, Kim J. 2021. Multilaboratory Evaluation of the MALDI-TOF Mass Spectrometry System, MicroIDSys Elite, for the Identification of Medically Important Filamentous Fungi. Mycopathologia 186:15-26.
  5. Kim SY, Kim DH, Moon SM, Song JY, Huh HJ, Lee NY, Shin SJ, Koh WJ, Jhun BW. 2021. Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates. Sci Rep 11:6108.
  6. Kim HJ, Kim IS, Lee SG, Kim YJ, Silwal P, Kim JY, Kim JK, Seo W, Chung C, Cho HK, Huh HJ, Shim SC, Park C, Jhun BW, Jo EK. 2021. MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus. Exp Mol Med 53:136-149.
  7. Kim H, Huh HJ, Park E, Chung DR, Kang M. 2021. Multiplex Molecular Point-of-Care Test for Syndromic Infectious Diseases. Biochip J doi:10.1007/s13206-021-00004-5:1-9.
  8. Kim DH, Kim SY, Huh HJ, Lee NY, Koh WJ, Jhun BW. 2021. In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, including Macrolide-/Amikacin-Resistant Clinical Isolates. Antimicrob Agents Chemother doi:10.1128/aac.02611-20.
  9. Kang N, Jeon K, Kim H, Kwon OJ, Huh HJ, Lee NY, Daley CL, Koh WJ, Jhun BW. 2021. Outcomes of inhaled amikacin-containing multidrug regimens for Mycobacterium abscessus pulmonary disease. Chest doi:10.1016/j.chest.2021.02.025.
  10. Huh HJ*, Hong KH, Kim TS, Song SH, Roh KH, Lee H, Kwon GC. 2021. Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea. Ann Lab Med 41:225-229.
  11. Ha C, Yoo IY, Yun SA, Chung YN, Huh HJ*, Lee NY. 2021. Performance evaluation of Automated Fluorescent Immunoassay System ROTA and NORO for detection of rotavirus and norovirus: A comparative study of assay performance with RIDASCREEN® Rotavirus and Norovirus. J Clin Lab Anal 35:e23585.
  12. Cho EH, Ki CS, Yun SA, Kim SY, Jhun BW, Koh WJ, Huh HJ*, Lee NY. 2021. Genetic Analysis of Korean Adult Patients with Nontuberculous Mycobacteria Suspected of Primary Ciliary Dyskinesia Using Whole Exome Sequencing. Yonsei Med J 62:224-230.
  13. Yu S, Huh HJ, Lee KW, Park JB, Kim SJ, Huh W, Jang HR, Kwon GY, Moon HH, Kang ES. 2020. Pre-Transplant Angiotensin II Type 1 Receptor Antibodies and Anti-Endothelial Cell Antibodies Predict Graft Function and Allograft Rejection in a Low-Risk Kidney Transplantation Setting. Ann Lab Med 40:398-408.
  14. Yoo IY, Kim JY, Yoon YK, Huh HJ*, Lee NY. 2020. Comparison Between the SFTS-QS Kit and the PowerChek SFTSV Real-time PCR Kit for the Detection of Severe Fever With Thrombocytopenia Syndrome Virus. Ann Lab Med 40:317-320.
  15. Yoo IY, Kang OK, Shim HJ, Huh HJ*, Lee NY. 2020. Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus in Korea: High Rate of False Resistance to Linezolid by the VITEK 2 System. Ann Lab Med 40:57-62.
  16. Yoo IY, Kang OK, Lee MK, Kim YJ, Cho SY, Huh K, Kang CI, Chung DR, Peck KR, Huh HJ*, Lee NY. 2020. Comparison of 16S Ribosomal RNA Targeted Sequencing and Culture for Bacterial Identification in Normally Sterile Body Fluid Samples: Report of a 10-Year Clinical Laboratory Review. Ann Lab Med 40:63-67.
  17. Yoo IY, Huh K, Shim HJ, Yun SA, Chung YN, Kang OK, Huh HJ*, Lee NY. 2020. Evaluation of the BioFire FilmArray Pneumonia Panel for rapid detection of respiratory bacterial pathogens and antibiotic resistance genes in sputum and endotracheal aspirate specimens. Int J Infect Dis 95:326-331.
  18. Shin S, Yoo IY, Shim HJ, Kang OK, Jhun BW, Koh WJ, Huh HJ*, Lee NY. 2020. Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens. Ann Lab Med 40:169-173.
  19. Oh S, Kim SH, Baek JY, Huh K, Cho SY, Kang CI, Chung DR, Huh HJ, Lee NY, Peck KR. 2020. A case of gonococcal meningitis caused by Neisseria gonorrhoeae MLST ST7363 in a healthy young adult. J Infect Chemother 26:995-998.
  20. Ogimi C, Kim YJ, Martin ET, Huh HJ, Chiu CH, Englund JA. 2020. What’s New With the Old Coronaviruses? J Pediatric Infect Dis Soc 9:210-217.
  21. Lee NH, Kang JM, Lee JW, Huh HJ, Lee NY, Yoo KH, Sung KW, Koo HH, Kim YJ. 2020. Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance. Pediatr Infect Dis J 39:931-936.
  22. Kwon WK, Choi S, Kim HJ, Huh HJ, Kang JM, Kim YJ, Yoo KH, Ahn K, Cho HK, Peck KR, Jang JH, Ki CS, Kang ES. 2020. Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience. Allergy Asthma Immunol Res 12:292-305.
  23. Ko RE, Jeong BH, Huh HJ, Lee NY, Yoo H, Jhun BW, Han J, Lee K, Kim H, Kwon OJ, Um SW. 2020. Clinical Usefulness of Fungal Culture of EBUS-TBNA Needle Rinse Fluid and Core Tissue. Yonsei Med J 61:670-678.
  24. Kim BG, Kim H, Kwon OJ, Huh HJ, Lee NY, Baek SY, Sohn I, Jhun BW. 2020. Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease. J Clin Med 9.
  25. Jhun BW, Moon SM, Jeon K, Kwon OJ, Yoo H, Carriere KC, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ. 2020. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study. Eur Respir J 55.
  26. Huh K, Chung DR, Ha YE, Ko JH, Kim SH, Kim MJ, Huh HJ, Lee NY, Cho SY, Kang CI, Peck KR, Song JH. 2020. Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data. Clin Infect Dis 71:e487-e496.
  27. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, Park JS, Kim GJ, Sung H, Roh KH, Kim JS, Kim HS, Lee ST, Seong MW, Ryoo N, Lee H, Kwon KC, Yoo CK. 2020. Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. Ann Lab Med 40:351-360.
  28. Heo WY, Lee JK, Chung YN, Yoo IY, Kang OK, Sung DH, Cho SY, Huh HJ*, Lee NY. 2020. First Case of Bacteremia Caused by Coprobacillus catenaformis. Ann Lab Med 40:421-423.
  29. Choi S, Kim YJ, Yoo KH, Sung KW, Koo HH, Kim SJ, Jang JH, Kim K, Jung CW, Huh HJ, Kang ES. 2020. Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults. Ann Lab Med 40:88-91.
  30. Cho EH, Huh HJ*, Jeong I, Lee NY, Koh WJ, Park HC, Ki CS. 2020. A nonsense variant in NME5 causes human primary ciliary dyskinesia with radial spoke defects. Clin Genet 98:64-68.
  31. Yoo IY, Song DJ, Huh HJ*, Lee NY. 2019. Simultaneous Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin A/B: Comparison of the C. DIFF QUIK CHEK COMPLETE and RIDASCREEN Assays. Ann Lab Med 39:214-217.
  32. Yoo IY, Huh HJ*, Kang OK, Jhun BW, Koh WJ, Lee NY. 2019. Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting. Respir Med 146:71-75.
  33. Moon SM, Yoo IY, Huh HJ, Lee NY, Jhun BW. 2019. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease. Antimicrob Agents Chemother 64.
  34. Moon SM, Jhun BW, Baek SY, Kim S, Jeon K, Ko RE, Shin SH, Lee H, Kwon OJ, Huh HJ, Ki CS, Lee NY, Chung MJ, Lee KS, Shin SJ, Daley CL, Koh WJ. 2019. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease. Respir Med 151:1-7.
  35. Moon SM, Choe J, Jhun BW, Jeon K, Kwon OJ, Huh HJ, Lee NY, Daley CL, Koh WJ. 2019. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease. Respir Med 148:37-42.
  36. Ko RE, Jeong BH, Chon HR, Huh HJ, Han J, Lee H, Lee K, Kim H, Kwon OJ, Um SW. 2019. Clinical usefulness of routine AFB culture and MTB PCR of EBUS-TBNA needle rinse fluid. Respirology 24:667-674.
  37. Kim SY, Moon SM, Jhun BW, Kwon OJ, Huh HJ, Lee NY, Lee SH, Shin SJ, Kasperbauer SH, Huitt GA, Daley CL, Koh WJ. 2019. Species Distribution and Macrolide Susceptibility of Mycobacterium fortuitum Complex Clinical Isolates. Antimicrob Agents Chemother 63.
  38. Kim SY, Jhun BW, Moon SM, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ. 2019. Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates. Diagn Microbiol Infect Dis 94:38-40.
  39. Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ. 2019. In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. Antimicrob Agents Chemother 63.
  40. Jung J, Yoo IY, Jhun BW, Koh WJ, Lee NY, Huh HJ*. 2019. First Isolation of Mycobacterium virginiense From a Human Pulmonary Specimen. Ann Lab Med 39:596-598.
  41. Huh HJ*, Song DJ, Ki CS, Lee NY. 2019. Is Cross-reactivity with Nontuberculous Mycobacteria a Systematic Problem in the Xpert MTB/RIF Assay? Tuberc Respir Dis (Seoul) 82:88-89.
  42. Huh HJ*, Lim KR, Ki CS, Huh K, Shim HJ, Song DJ, Kim YJ, Chung DR, Lee NY. 2019. Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients. Ann Lab Med 39:176-182.
  43. Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY. 2019. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance. J Clin Microbiol 57. 44.Huh HJ, Kim SY, Jhun BW, Shin SJ, Koh WJ. 2019. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases. Infect Genet Evol 72:169-182.
  44. Huh HJ*, Ki CS, Yun SA, Lee J, Oh GY, Lee NS, Yoon YH, Lee NY. 2019. Comparison between DiaPlexQ™ STI6 and GeneFinder™ STD I/STD II multiplex Real-time PCR Kits in the detection of six sexually transmitted disease pathogens. J Clin Lab Anal 33:e22703.
  45. Choi Y, Jhun BW, Kim J, Huh HJ, Lee NY. 2019. Clinical Characteristics and Outcomes of Surgically Resected Solitary Pulmonary Nodules Due to Nontuberculous Mycobacterial Infections. J Clin Med 8.
  46. Cho EH, Huh HJ*, Song DJ, Lee SH, Kim CK, Shin SY, Ki CS, Jhun BW, Moon SM, Kwon OJ, Koh WJ, Lee NY. 2019. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens. Diagn Microbiol Infect Dis 93:107-111.
  47. Park MS, Yoo IY, Kang OK, Lee JE, Kim DJ, Huh HJ*, Lee NY. 2019. Evaluation of BacT/Alert FAN Plus Bottles for the Culture of Peritoneal Dialysate. Ann Clin Microbiol 22:90-95.
  48. Jhun BW, Huh HJ*, Koh WJ. Diagnosis of pulmonary tuberculosis. J Korean Med Assoc 62:18-24.
  49. Shin SH, Jhun BW, Kim SY, Choe J, Jeon K, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. 2018. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex. Antimicrob Agents Chemother 62.
  50. Oh J, Yoo IY, Song DJ, Lee JW, Kim YJ, Ki CS, Lee NY, Huh HJ*. 2018. A Case of Cruoricaptor ignavus Isolated From the Blood of a Patient With Ewing Sarcoma. Ann Lab Med 38:613-615.
  51. Kim SY, Jhun BW, Moon SM, Shin SH, Jeon K, Kwon OJ, Yoo IY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Suh GY, Koh WJ. 2018. Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates. Antimicrob Agents Chemother 62.
  52. Kang JM, Park KS, Kim JM, Huh HJ, Ki CS, Lee NY, Yoo KH, Sung KW, Koo HH, Kim YJ. 2018. Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: A single-center study in Korea. Transpl Infect Dis 20:e12885.
  53. Jhun BW, Kim SY, Moon SM, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. 2018. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease. Am J Respir Crit Care Med 198:1322-1330.
  54. Huh HJ*, Song DJ, Shim HJ, Kwon WK, Park MS, Ryu MR, Cho EH, Oh J, Yoo IY, Lee NY. 2018. Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system. J Antimicrob Chemother 73:1267-1271.
  55. Huh HJ*, Jhun BW, Choi SR, Kim YJ, Yun SA, Nham E, Kong T, Ki CS, Koh WJ. 2018. Bronchiectasis and Recurrent Respiratory Infections with a De Novo STAT1 Gain-of-Function Variant: First Case in Korea. Yonsei Med J 59:1004-1007.
  56. Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. 2018. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. Diagn Microbiol Infect Dis 90:293-295.
  57. Cho SY, Kim HM, Chung DR, Kim SH, Huh HJ, Kang CI, Peck KR, Lee NY, Song JH. 2018. Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: A single-centre study in South Korea. J Glob Antimicrob Resist 12:44-47.
  58. Cho EH, Huh HJ*, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY. 2018. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens. J Infect Chemother 24:315-318.
TOPへ